Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial. - Janani L; Munro APS; Wright A; Aley PK; Babbage G; Baxter D; Bawa T; Bibi S; Bula M; Cathie K; Chatterjee K; Cosgrove C; et al. (The Journal of infection, 2025)